Aberdeen Group’s Apnimed Inc APMD Stock Holding History

Aberdeen Group’s Portfolio APMD Stock Details APMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$20.7M	Buy	+945,078	New	+$25.4M	0.03%	461

Other funds holding APMD

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

Asset Planning Inc Cypress, California $152M AUM 19.47% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Clearstead Advisors Cleveland, Ohio $10.8B AUM 17.88% 1-Year Est. Return

Aberdeen Group's APMD Position: Q3 2026 in Review

Aberdeen Group opened a new position in Apnimed Inc (APMD) in Q3 2026: 945,078 shares worth $20.7M. The stake represents 0.03% of the portfolio and ranks #461 among its holdings.

15 funds tracked by Wall St. Rank hold APMD as of Q3 2026.

Aberdeen Group held 945,078 shares of Apnimed Inc worth $20.7M as of Q3 2026.
Apnimed Inc was a new Aberdeen Group position in Q3 2026.
Apnimed Inc made up 0.03% of Aberdeen Group's portfolio in Q3 2026, its #461 holding.
15 funds tracked by Wall St. Rank held Apnimed Inc as of Q3 2026.

Based on Aberdeen Group's 13F filing for Q3 2026, filed 6 Nov 2026.